Using attenuated Salmonella typhi as tumor targeting vector for MDR1 siRNA delivery: An experimental study

Cancer Biology and Therapy

Volumn 6, Issue 4, 2007, Pages 555-560

  Jiang, Zhongming ^a,b   Zhao, Ping ^a   Zhou, Zhonghua ^a   Liu, Jun ^a   Qin, Liying ^a   Wang, Hongwei ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gene therapy; Multidrug resistance gene; Salmonella typhi; Small interference RNA; Squamous cell carcinoma; Tumor; Vector

Indexed keywords

CISPLATIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; PLASMID VECTOR; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; FEMALE; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; MOUSE; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; SALMONELLA TYPHI; SQUAMOUS CELL CARCINOMA; TONGUE CANCER; WESTERN BLOTTING;

EID: 34548277482     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.4.3850     Document Type: Article

References (29)

1. Ling V. Multidrug resistance and P-glycoprotein expression. Ann N Y Acad Sci 1987; 507:7-8.
2. Schurr E, Raymond M, Bell JC, Gros P. Characterization of the multidrug resistance protein expressed in cell clones stably transfected with the mouse mdr1 cDNA. Cancer Res 1989; 49:2729-33.
3. Dean M, Rzhetsky A, Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 2001; 11:1156-66.
4. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat Rev Cancer 2002; 2:48-58.
5. Ueda K, Cornwell MM, Gottesman MM, Pastan I, Roninson IB, Ling V, Riordan JR. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun 1986; 141:956-962.
6. Ueda K, Cardarelli C, Gottesman MM, Pastan I. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 1987; 84:3004-8.
7. Park JG, Kramer BS, Lai SL, Goldstein LJ, Gazdar AF. Chemosensitivity patterns and expression of human multidrug resistance-associated MDR1 gene by human gastric and colorectal carcinoma cell lines. J Natl Cancer Inst 1990; 82:193-8.
8. Hannon GJ. RNA interference. Nature 2002; 418:244-51.
9. Stevenson M. Therapeutic potential of RNA interference. N Engl J Med 2004; 351:1772-77.
10. Nieth C, Priebsch A, Stege A, Lage H. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi). FEBS Lett 2003; 545:144-50.
11. Li L, Xu J, Min T, Huang W. Reversal of MDR1 gene-dependent multidrug resistance using low concentration of endonuclease-prepared small interference RNA. Eur J Pharmacol 2006; 536:93-7.
12. Lage H. MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance. Curr Drug Targets 2006; 7:813-21.
13. Jiang ZM, Zhao P, Gao J, Zhan XB, Lv CT. Recombinant Attenuated salmonella typhimurium Haboring TIP30 and Human IFN-γ genes inhibits the growth of adenoid cystic carcinoma in vivo. Chinese Journal of Cancer Biotherapy 2004; 11:42-5, (Chinese).
14. Nitta A, Chung YS, Nakata B, Yashiro M, Onoda N, Maeda K, Sawada T, Sowa M. Establishment of a cisplatin-resistant gastric carcinoma cell line OCUM-2M/DDP. Cancer Chemother Pharmacol 1997; 40:94-7.
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8.
16. Wu H, Hait WN, Yang JM. Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res 2003; 63:1515-19.
17. Gou D, Jin N, Liu L. Gene silencing in mammalian cells by PCR-based short hairpin RNA. FEBS Lett 2003; 548:113-8.
18. Zhao P, Qin ZL, Ke JS, Lu Y, Liu M, Pan W, Zhao LJ, Cao J, Qi ZT. Small interfering RNA inhibits SARS-CoV nucleocapsid gene expression in cultured cells and mouse muscles. FEBS Lett 2005; 579:2404-10.
19. Xiang R, Lode HN, Chao TH, Ruehlmann JM, Dolman CS, Rodriguez F, Whitton JL, Overwijk WW, Restifo NP, Reisfeld RA. An autologous oral DNA vaccine protects against murine melanoma. Proc Natl Acad Sci USA 2000; 97:5492-7.
20. Clutterbuck RD, Hills CA, Hoey P, Alexander P, Powles RL, Millar JL. Studies on the development of human acute myeloid leukaemia xenografts in immune-deprived mice: Comparison with cells in short-term culture. Leuk Res 1985; 9:1511-8.
21. Mahadevan D, Shirahatti N. Strategies for targeting the multidrug resistance-1 (MDR1)/P-gp transporter in human malignancies. Curr Cancer Drug Targets 2005; 5:445-55.
22. Goldstein LJ. MDR1 gene expression in solid tumours. Eur J Cancer 1996; 32A:1039-50.
23. Sirard JC, Niedergang F, Kraehenbuhl JP. Live attenuated Salmonella: A paradigm of mucosal vaccines. Immunol Rev 1999; 171:5-26.
24. Newton SM, Jacob CO, Stocker BA. Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science 1989; 244:70-2.
25. Darji A, Guzman CA, Gerstel B, Wachholz P, Timmis KN, Wehland J, Chakraborty T, Weiss S. Oral somatic transgene vaccination using attenuated S.typhimurium. Cell 1997; 91:765-75.
26. Paglia P, Medina E, Arioli I, Guzman CA, Colombo MP. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood 1998; 92:3172-6.
27. Bermudes D, Low B, Pawelek J. Tumor-targeted Salmonella: Highly selective delivery vectors. Adv Exp Med Biol 2000; 465:57-63.
28. Pawelek JM, Low KB, Bermudes D. Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 1997; 57:4537-44.
29. Zhou XJ, Li Q, Chen WT. Establishment and drug-resistance gene expression of cisplatin-resistant cell line Tca8113/CDDP. Shanghai Kou Qiang Yi Xue 2003; 12:432-5, (Chinese).